Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (461-470 of 475) with videos related to

Pageof 48
Sort By:
Scientific Reports|October 15, 2020
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologistsLina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, et al.
European Urology|April 22, 2020
Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS StudyAhmed El-Shater Bosaily, Elena Frangou, Hashim U Ahmed, et al.
Radiology|December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS TrialVasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
BMJ Open|January 24, 2023
Protocol for a MULTI-centre feasibility study to assess the use of <sup>99m</sup>Tc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)Hannah Warren, Thomas Wagner, Michael A Gorin, et al.
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2025
[<sup>99m</sup>Tc]Tc-sestamibi SPECT/CT for the diagnosis of kidney tumours: a multi-centre feasibility study (MULTI-MIBI Study)Hannah Warren, Thomas Wagner, Soha El-Sheikh, et al.
European Urology|October 14, 2020
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMISVasilis Stavrinides, Tom Syer, Yipeng Hu, et al.
JAMA Oncology|February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate CancerAlexander Light, Max Peters, Manit Arya, et al.
Prostate Cancer and Prostatic Diseases|July 24, 2023
From BPH to male LUTS: a 20-year journey of the EAU guidelinesStavros Gravas, Sachin Malde, Jean-Nicolas Cornu, et al.
European Urology Focus|October 13, 2020
The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with BiopsyThomas Stonier, Nick Simson, Taimur Shah, et al.
Pageof 48

Showing results (461-470 of 475) with videos related to

Sort By:
Pageof 48
Scientific Reports|October 15, 2020
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologistsLina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, et al.
European Urology|April 22, 2020
Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS StudyAhmed El-Shater Bosaily, Elena Frangou, Hashim U Ahmed, et al.
Radiology|December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS TrialVasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
BMJ Open|January 24, 2023
Protocol for a MULTI-centre feasibility study to assess the use of <sup>99m</sup>Tc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)Hannah Warren, Thomas Wagner, Michael A Gorin, et al.
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2025
[<sup>99m</sup>Tc]Tc-sestamibi SPECT/CT for the diagnosis of kidney tumours: a multi-centre feasibility study (MULTI-MIBI Study)Hannah Warren, Thomas Wagner, Soha El-Sheikh, et al.
European Urology|October 14, 2020
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMISVasilis Stavrinides, Tom Syer, Yipeng Hu, et al.
JAMA Oncology|February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate CancerAlexander Light, Max Peters, Manit Arya, et al.
Prostate Cancer and Prostatic Diseases|July 24, 2023
From BPH to male LUTS: a 20-year journey of the EAU guidelinesStavros Gravas, Sachin Malde, Jean-Nicolas Cornu, et al.
European Urology Focus|October 13, 2020
The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with BiopsyThomas Stonier, Nick Simson, Taimur Shah, et al.
Pageof 48